Chromic phosphate, also known as chromium(III) phosphate, is an inorganic compound with the chemical formula CrPO4. It is a green, crystalline solid that is insoluble in water but soluble in acids. Chromic phosphate is used as a pigment in paints, ceramics, and plastics. It is also used as a catalyst in various chemical reactions. It is studied due to its potential applications in catalysis, pigments, and as a corrosion inhibitor. It can be synthesized by reacting chromic oxide (Cr2O3) with phosphoric acid (H3PO4). '
chromic phosphate: P32 labeled is separate SCR since that is form of major interest [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 62673 |
| MeSH ID | M0080520 |
| Synonym |
|---|
| einecs 232-141-0 |
| chromium phosphate |
| chromium orthophosphate |
| phosphoric acid chromium (iii) salt |
| phosphoric acid, chromium(3+) salt (1:1) |
| chromium monophosphate |
| chromic phosphate |
| 7789-04-0 |
| aq86zj9u98 , |
| unii-aq86zj9u98 |
| chromium(iii) phosphate |
| phosphoric acid chromium(3+) salt (1:1) |
| chromic phosphate [mi] |
| chromphosphat |
| Q4337167 |
| chromium(iii)phosphate |
| IKZBVTPSNGOVRJ-UHFFFAOYSA-K |
| DTXSID70884435 |
| chromium(3+);phosphate |
| chromium (iii) phosphate |
| chromium phosphoricum |
| Excerpt | Reference | Relevance |
|---|---|---|
| "The chromic phosphate has no gamma radiation to complicate the health physics." | ( Use of radioactive chromic phosphate in pleural effusions. JACOBS, ML, 1954) | 1.04 |
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we focused on chromium allergy and extended our earlier observations by further dose-response studies." | ( Oral induction of immunological tolerance to chromium in the guinea pig. de Groot, K; Scheper, RJ; Van Hoogstraten, IM; Von Blomberg, BM; Vreeburg, KJ, 1990) | 0.28 |
| " The extent of irradiative injury in ILN was positively correlated to the dosage of medication." | ( Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: mechanism involved. Feng, GS; Gao, H; Gao, W; Huang, Y; Li, C; Liu, L; Tong, GS; Wang, Y, 2005) | 0.33 |
| " The TIR of each dosage group in order was 21." | ( Intratumoral injection of 32P-chromic phosphate in the treatment of implanted pancreatic carcinoma. Gao, W; Jiang, B; Liu, L; Liu, XN; Liu, ZY; Wang, Y, 2010) | 0.65 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 99 (66.00) | 18.7374 |
| 1990's | 29 (19.33) | 18.2507 |
| 2000's | 14 (9.33) | 29.6817 |
| 2010's | 7 (4.67) | 24.3611 |
| 2020's | 1 (0.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (18.20) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 11 (6.92%) | 5.53% |
| Reviews | 4 (2.52%) | 6.00% |
| Case Studies | 12 (7.55%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 132 (83.02%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Relationship Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|
| chlorine chloride : A halide anion formed when chlorine picks up an electron to form an an anion. | 1.97 | 1 | 0 | halide anion; monoatomic chlorine | cofactor; Escherichia coli metabolite; human metabolite |
| lactic acid Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed). 2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group. | 7.48 | 2 | 0 | 2-hydroxy monocarboxylic acid | algal metabolite; Daphnia magna metabolite |
| phosphoric acid phosphoric acid: concise etchant is 37% H3PO4. phosphoric acid : A phosphorus oxoacid that consists of one oxo and three hydroxy groups joined covalently to a central phosphorus atom. | 2.04 | 1 | 0 | phosphoric acids | algal metabolite; fertilizer; human metabolite; NMR chemical shift reference compound; solvent |
| sodium iodide Sodium Iodide: A compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive (I-131) form as an diagnostic aid, particularly for thyroid function tests.. sodium iodide : A metal iodide salt with a Na(+) counterion. | 2.03 | 1 | 0 | inorganic sodium salt; iodide salt | |
| isoprene isoprene: used in manufacture of ''synthetic'' rubber, butyl rubber; copolymer in production of elastomers; structure. isoprene : A hemiterpene with the formula CH2=C(CH3)CH=CH2; the monomer of natural rubber and a common structure motif to the isoprenoids, a large class of other naturally occurring compounds. | 2.04 | 1 | 0 | alkadiene; hemiterpene; volatile organic compound | plant metabolite |
| tetralin tetralin: structure given in first source. tetralin : An ortho-fused bicyclic hydrocarbon that is 1,2,3,4-tetrahydro derivative of naphthalene. | 2.05 | 1 | 0 | ortho-fused bicyclic hydrocarbon; tetralins | |
| technetium Technetium: The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, and atomic number 43. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years. | 4.05 | 3 | 1 | manganese group element atom | |
| chromium Chromium: A trace element that plays a role in glucose metabolism. It has the atomic symbol Cr, atomic number 24, and atomic weight 52. According to the Fourth Annual Report on Carcinogens (NTP85-002,1985), chromium and some of its compounds have been listed as known carcinogens.. chromium ion : An chromium atom having a net electric charge.. chromium atom : A chromium group element atom that has atomic number 24. | 9.36 | 84 | 4 | chromium group element atom; metal allergen | micronutrient |
| gold Gold: A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts. | 6.93 | 1 | 0 | copper group element atom; elemental gold | |
| yttrium Yttrium: An element of the rare earth family of metals. It has the atomic symbol Y, atomic number 39, and atomic weight 88.91. In conjunction with other rare earths, yttrium is used as a phosphor in television receivers and is a component of the yttrium-aluminum garnet (YAG) lasers. | 2.33 | 2 | 0 | d-block element atom; rare earth metal atom; scandium group element atom | |
| phosphoric acid, trisodium salt [no description available] | 2.69 | 3 | 0 | sodium phosphate | |
| chromates Chromates: Salts of chromic acid containing the CrO(2-)4 radical.. chromate(2-) : A chromium oxoanion resulting from the removal of two protons from chromic acid. | 1.93 | 1 | 0 | chromium oxoanion; divalent inorganic anion | oxidising agent |
| chromium chromium hexavalent ion: a human respiratory carcinogen | 2.05 | 1 | 0 | chromium cation; monoatomic hexacation | |
| phenyl acetate phenyl acetate: The ester formed between phenol and acetic acid. Don't confuse with phenylacetic acid derivatives listed under PHENYLACETATES.. phenyl acetate : An acetate ester obtained by the formal condensation of phenol with acetic acid. | 2.05 | 1 | 0 | benzenes; phenyl acetates | |
| aluminum phosphate aluminum phosphate: gel used as immunologic adjuvent; RN given refers to Al salt | 2.05 | 1 | 0 | ||
| cobalt Cobalt: A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.. cobalt(1+) : A monovalent inorganic cation obtained from cobalt.. cobalt atom : A cobalt group element atom that has atomic number 27. | 2.05 | 1 | 0 | cobalt group element atom; metal allergen | micronutrient |
| yttrium radioisotopes Yttrium Radioisotopes: Unstable isotopes of yttrium that decay or disintegrate emitting radiation. Y atoms with atomic weights 82-88 and 90-96 are radioactive yttrium isotopes. | 2.03 | 1 | 0 | ||
| melphalan Melphalan: An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen.. melphalan : A phenylalanine derivative comprising L-phenylalanine having [bis(2-chloroethyl)amino group at the 4-position on the phenyl ring. | 11.55 | 4 | 4 | L-phenylalanine derivative; nitrogen mustard; non-proteinogenic L-alpha-amino acid; organochlorine compound | alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent |
| lead Lead: A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb. | 2.02 | 1 | 0 | carbon group element atom; elemental lead; metal atom | neurotoxin |
| sulfur Sulfur: An element that is a member of the chalcogen family. It has an atomic symbol S, atomic number 16, and atomic weight [32.059; 32.076]. It is found in the amino acids cysteine and methionine. | 2.36 | 2 | 0 | chalcogen; nonmetal atom | macronutrient |
| astatine Astatine: Astatine. A radioactive halogen with the atomic symbol At, and atomic number 85. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism because it emits ALPHA PARTICLES. | 1.96 | 1 | 0 | elemental astatine | |
| phosphorus Phosphorus: A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. | 4.41 | 23 | 0 | monoatomic phosphorus; nonmetal atom; pnictogen | macronutrient |
| strontium radioisotopes Strontium Radioisotopes: Unstable isotopes of strontium that decay or disintegrate spontaneously emitting radiation. Sr 80-83, 85, and 89-95 are radioactive strontium isotopes. | 2.03 | 1 | 0 | ||
| tellurium Tellurium: An element that is a member of the chalcogen family. It has the atomic symbol Te, atomic number 52, and atomic weight 127.60. It has been used as a coloring agent and in the manufacture of electrical equipment. Exposure may cause nausea, vomiting, and CNS depression. | 1.96 | 1 | 0 | chalcogen; metalloid atom | |
| technetium tc 99m sulfur colloid Technetium Tc 99m Sulfur Colloid: A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen. | 5.71 | 6 | 1 | ||
| phosphorus radioisotopes Phosphorus Radioisotopes: Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes. | 11.99 | 80 | 9 |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Autosomal Hemophilia A [description not available] | 0 | 3.1 | 5 | 0 |
| Plica Syndrome [description not available] | 0 | 3.09 | 5 | 0 |
| Hemarthrosis Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia. | 0 | 8.25 | 6 | 0 |
| Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. | 0 | 3.1 | 5 | 0 |
| Synovitis Inflammation of the SYNOVIAL MEMBRANE. | 0 | 3.09 | 5 | 0 |
| Glial Cell Tumors [description not available] | 0 | 2.66 | 3 | 0 |
| Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) | 0 | 2.66 | 3 | 0 |
| Delayed Hypersensitivity [description not available] | 0 | 2.05 | 1 | 0 |
| Aneurysmal Bone Cysts [description not available] | 0 | 2.43 | 2 | 0 |
| Cancer of Pancreas [description not available] | 0 | 4.5 | 5 | 1 |
| Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). | 0 | 4.5 | 5 | 1 |
| Lymph Node Metastasis [description not available] | 0 | 2.39 | 2 | 0 |
| Cancer of Prostate [description not available] | 0 | 3.88 | 13 | 0 |
| Prostatic Neoplasms Tumors or cancer of the PROSTATE. | 0 | 3.88 | 13 | 0 |
| Cancer of Ovary [description not available] | 0 | 11.34 | 37 | 9 |
| Peritoneal Carcinomatosis [description not available] | 0 | 3.07 | 5 | 0 |
| Adenocarcinoma, Papillary An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed) | 0 | 2.01 | 1 | 0 |
| Ascites Accumulation or retention of free fluid within the peritoneal cavity. | 0 | 3.34 | 7 | 0 |
| Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. | 0 | 11.34 | 37 | 9 |
| Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. | 0 | 3.07 | 5 | 0 |
| Carcinoma, Anaplastic [description not available] | 0 | 7.04 | 12 | 3 |
| Local Neoplasm Recurrence [description not available] | 0 | 6.7 | 7 | 2 |
| Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer. | 0 | 7.04 | 12 | 3 |
| Benign Neoplasms [description not available] | 0 | 5.62 | 19 | 1 |
| Cancer of the Tongue [description not available] | 0 | 1.93 | 1 | 0 |
| Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 5.62 | 19 | 1 |
| Tongue Neoplasms Tumors or cancer of the TONGUE. | 0 | 1.93 | 1 | 0 |
| Disease A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown. | 0 | 2.33 | 2 | 0 |
| Pleural Diseases Diseases involving the PLEURA. | 0 | 2.63 | 3 | 0 |
| Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. | 0 | 3.34 | 7 | 0 |
| Bladder Cancer [description not available] | 0 | 3.63 | 10 | 0 |
| Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. | 0 | 3.63 | 10 | 0 |
| Cancer of the Urinary Tract [description not available] | 0 | 2.33 | 2 | 0 |
| Pleural Effusion, Malignant Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells. | 0 | 3.04 | 5 | 0 |
| Pleurisy INFLAMMATION of PLEURA, the lining of the LUNG. When PARIETAL PLEURA is involved, there is pleuritic CHEST PAIN. | 0 | 1.93 | 1 | 0 |
| Neuroma A tumor made up of nerve cells and nerve fibers. (Dorland, 27th ed) | 0 | 6.93 | 1 | 0 |
| Bleeding [description not available] | 0 | 2.36 | 2 | 0 |
| Hemorrhage Bleeding or escape of blood from a vessel. | 0 | 7.36 | 2 | 0 |
| Cancer of Lung [description not available] | 0 | 4.82 | 4 | 2 |
| Lung Neoplasms Tumors or cancer of the LUNG. | 0 | 4.82 | 4 | 2 |
| Eosinophilia, Tropical [description not available] | 0 | 1.93 | 1 | 0 |
| Leukocytopenia [description not available] | 0 | 1.93 | 1 | 0 |
| Circulatory Collapse [description not available] | 0 | 1.93 | 1 | 0 |
| Endotoxin Shock [description not available] | 0 | 1.93 | 1 | 0 |
| Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. | 0 | 1.93 | 1 | 0 |
| Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). | 0 | 1.93 | 1 | 0 |
| Shock A pathological condition manifested by failure to perfuse or oxygenate vital organs. | 0 | 1.93 | 1 | 0 |
| Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. | 0 | 1.93 | 1 | 0 |
| Leucocythaemia [description not available] | 0 | 2.34 | 2 | 0 |
| Leukemia, Lymphocytic [description not available] | 0 | 1.93 | 1 | 0 |
| Granulocytic Leukemia [description not available] | 0 | 1.93 | 1 | 0 |
| Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) | 0 | 7.34 | 2 | 0 |
| Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. | 0 | 1.93 | 1 | 0 |
| Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. | 0 | 1.93 | 1 | 0 |
| Brain Disorders [description not available] | 0 | 1.93 | 1 | 0 |
| Cyst [description not available] | 0 | 2.65 | 3 | 0 |
| Cancer of Pituitary [description not available] | 0 | 2.87 | 4 | 0 |
| Craniopharyngioma, Adamantinous [description not available] | 0 | 2.87 | 4 | 0 |
| Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. | 0 | 1.93 | 1 | 0 |
| Craniopharyngioma A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50) | 0 | 7.87 | 4 | 0 |
| Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. | 0 | 2.87 | 4 | 0 |
| Benign Neoplasms, Brain [description not available] | 0 | 2.64 | 3 | 0 |
| Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. | 0 | 2.64 | 3 | 0 |
| Neoplasms, Bronchial [description not available] | 0 | 1.93 | 1 | 0 |
| Bronchial Neoplasms Tumors or cancer of the BRONCHI. | 0 | 1.93 | 1 | 0 |
| Liver Dysfunction [description not available] | 0 | 1.93 | 1 | 0 |
| Liver Diseases Pathological processes of the LIVER. | 0 | 1.93 | 1 | 0 |
| Adenocarcinoma, Endometrioid [description not available] | 0 | 4.31 | 1 | 1 |
| Carcinoma, Colloid [description not available] | 0 | 4.31 | 1 | 1 |
| Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) | 0 | 4.31 | 1 | 1 |
| Carcinoma, Endometrioid An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues. | 0 | 4.31 | 1 | 1 |
| Cystadenocarcinoma, Serous A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185) | 0 | 4.31 | 1 | 1 |
| Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. | 0 | 1.92 | 1 | 0 |
| Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) | 0 | 2.02 | 1 | 0 |
| Bone Cancer [description not available] | 0 | 2.03 | 1 | 0 |
| Hyperthyroid [description not available] | 0 | 2.03 | 1 | 0 |
| Diffuse Mixed Small and Large Cell Lymphoma [description not available] | 0 | 2.03 | 1 | 0 |
| Ache [description not available] | 0 | 2.03 | 1 | 0 |
| Erythremia [description not available] | 0 | 2.03 | 1 | 0 |
| Thrombopenia [description not available] | 0 | 2.03 | 1 | 0 |
| Cancer of the Thyroid [description not available] | 0 | 2.03 | 1 | 0 |
| Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. | 0 | 2.03 | 1 | 0 |
| Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. | 0 | 2.03 | 1 | 0 |
| Lymphoma, Non-Hodgkin Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. | 0 | 2.03 | 1 | 0 |
| Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. | 0 | 2.03 | 1 | 0 |
| Polycythemia Vera A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs. | 0 | 2.03 | 1 | 0 |
| Thrombocytopenia A subnormal level of BLOOD PLATELETS. | 0 | 2.03 | 1 | 0 |
| Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. | 0 | 2.03 | 1 | 0 |
| Cancer of Skin [description not available] | 0 | 2.04 | 1 | 0 |
| Skin Neoplasms Tumors or cancer of the SKIN. | 0 | 2.04 | 1 | 0 |
| Adenocarcinoma, Basal Cell [description not available] | 0 | 5.23 | 12 | 1 |
| Adenocarcinoma A malignant epithelial tumor with a glandular organization. | 0 | 5.23 | 12 | 1 |
| Neoplasms, Pleural [description not available] | 0 | 1.96 | 1 | 0 |
| Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) | 0 | 1.96 | 1 | 0 |
| Acute Liver Injury, Drug-Induced [description not available] | 0 | 1.96 | 1 | 0 |
| Alveolitis, Fibrosing [description not available] | 0 | 1.96 | 1 | 0 |
| Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. | 0 | 1.96 | 1 | 0 |
| Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. | 0 | 1.96 | 1 | 0 |
| Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. | 0 | 1.96 | 1 | 0 |
| Cancer of the Uterus [description not available] | 0 | 2.88 | 4 | 0 |
| Uterine Neoplasms Tumors or cancer of the UTERUS. | 0 | 2.88 | 4 | 0 |
| Cancer of Colon [description not available] | 0 | 2.65 | 3 | 0 |
| Cancer of Liver [description not available] | 0 | 4.05 | 3 | 1 |
| Colonic Neoplasms Tumors or cancer of the COLON. | 0 | 2.65 | 3 | 0 |
| Liver Neoplasms Tumors or cancer of the LIVER. | 0 | 4.05 | 3 | 1 |
| Cystadenocarcinoma A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed) | 0 | 2.88 | 4 | 0 |
| Complications, Neoplastic Pregnancy [description not available] | 0 | 1.96 | 1 | 0 |
| Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. | 0 | 1.96 | 1 | 0 |
| Cancer of Rectum [description not available] | 0 | 1.96 | 1 | 0 |
| Rectal Neoplasms Tumors or cancer of the RECTUM. | 0 | 1.96 | 1 | 0 |
| Fistula Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body. | 0 | 1.96 | 1 | 0 |
| Bronchial Fistula An abnormal passage or communication between a bronchus and another part of the body. | 0 | 1.96 | 1 | 0 |
| Experimental Neoplasms [description not available] | 0 | 1.96 | 1 | 0 |
| Peritoneal Diseases Pathological processes involving the PERITONEUM. | 0 | 1.96 | 1 | 0 |
| Cancer of Cervix [description not available] | 0 | 3.29 | 2 | 0 |
| Metastase [description not available] | 0 | 1.96 | 1 | 0 |
| Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. | 0 | 3.29 | 2 | 0 |
| Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. | 0 | 1.96 | 1 | 0 |
| Breast Cancer [description not available] | 0 | 3.76 | 2 | 1 |
| Breast Neoplasms Tumors or cancer of the human BREAST. | 0 | 3.76 | 2 | 1 |
| Female Genital Neoplasms [description not available] | 0 | 2.9 | 1 | 0 |
| Cancer of Endometrium [description not available] | 0 | 3.3 | 2 | 0 |
| Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). | 0 | 2.9 | 1 | 0 |
| Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. | 0 | 3.3 | 2 | 0 |
| Adnexitis Inflammation of the uterine appendages (ADNEXA UTERI) including infection of the FALLOPIAN TUBES (SALPINGITIS), the ovaries (OOPHORITIS), or the supporting ligaments (PARAMETRITIS). | 0 | 1.98 | 1 | 0 |
| Injuries, Radiation [description not available] | 0 | 3.77 | 2 | 1 |
| Cystadenoma, Mucinous A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential. | 0 | 1.98 | 1 | 0 |
| Pelvic Inflammatory Disease A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility. | 0 | 1.98 | 1 | 0 |
| Recrudescence [description not available] | 0 | 1.98 | 1 | 0 |
| Extravasation of Contrast Media [description not available] | 0 | 1.99 | 1 | 0 |
| Cancer of Head [description not available] | 0 | 4.34 | 2 | 2 |
| Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) | 0 | 4.34 | 2 | 2 |
| Experimental Mammary Neoplasms [description not available] | 0 | 2.39 | 2 | 0 |
| Cancer of Digestive System [description not available] | 0 | 3.38 | 1 | 1 |
| Hepatocellular Carcinoma [description not available] | 0 | 3.38 | 1 | 1 |
| Digestive System Neoplasms Tumors or cancer of the DIGESTIVE SYSTEM. | 0 | 3.38 | 1 | 1 |
| Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 0 | 3.38 | 1 | 1 |
| Cancer, Second Primary [description not available] | 0 | 3.39 | 1 | 1 |
| Spinal Diseases Diseases involving the SPINE. | 0 | 2 | 1 | 0 |
| Chronic Illness [description not available] | 0 | 2.41 | 2 | 0 |
| Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). | 0 | 2.41 | 2 | 0 |
| Dermatitis Medicamentosa [description not available] | 0 | 1.97 | 1 | 0 |
| Allergy, Drug [description not available] | 0 | 1.97 | 1 | 0 |
| Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. | 0 | 1.97 | 1 | 0 |
| Agnogenic Myeloid Metaplasia [description not available] | 0 | 1.97 | 1 | 0 |
| Chylopericardium [description not available] | 0 | 1.97 | 1 | 0 |
| Pericardial Effusion Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE. | 0 | 6.97 | 1 | 0 |
| Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. | 0 | 1.97 | 1 | 0 |
| Colonic Diseases Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE). | 0 | 1.97 | 1 | 0 |
| Intestinal Perforation Opening or penetration through the wall of the INTESTINES. | 0 | 1.97 | 1 | 0 |
| Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. | 0 | 2.38 | 2 | 0 |
| Experimental Leukemia [description not available] | 0 | 1.97 | 1 | 0 |
| Polyarthritis [description not available] | 0 | 1.97 | 1 | 0 |
| Adjuvant Arthritis [description not available] | 0 | 1.97 | 1 | 0 |
| Experimental Radiation Injuries [description not available] | 0 | 1.97 | 1 | 0 |
| Arthritis Acute or chronic inflammation of JOINTS. | 0 | 6.97 | 1 | 0 |
| Endometrioma An enlarged area of ENDOMETRIOSIS that resembles a tumor. It is usually found in the OVARY. When it is filled with old blood, it is known as a chocolate cyst. | 0 | 1.97 | 1 | 0 |
| Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. | 0 | 1.97 | 1 | 0 |
| Carcinoma, Papillary A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed) | 0 | 1.97 | 1 | 0 |
| Anaplastic Astrocytoma [description not available] | 0 | 1.96 | 1 | 0 |
| Brain Ventricular Neoplasms [description not available] | 0 | 1.96 | 1 | 0 |
| Astrocytoma Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082) | 0 | 1.96 | 1 | 0 |